Clinical Trials Logo

Alcoholic Liver Cirrhosis clinical trials

View clinical trials related to Alcoholic Liver Cirrhosis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02806011 Completed - Clinical trials for Alcoholic Liver Cirrhosis

Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 Study

Start date: May 2016
Phase:
Study type: Observational

This is a 5-year (+30 days) long term follow up study to evaluate the safety of Livercellgram in subject who participated in and completed the Livercellgram Phase 2 trials (refer to ClinicalTrials.gov.Identifier: NCT01875081).

NCT ID: NCT01875081 Completed - Clinical trials for Alcoholic Liver Cirrhosis

REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)

Start date: November 2012
Phase: Phase 2
Study type: Interventional

If the participant voluntarily agrees to participate in the clinical trial before registration, the investigator conducts a screening test to evaluate the participant's suitability. A participant that satisfies all selection and exclusion criteria is assigned randomly to a test group (1-time or 2-time injection group) or control group (no-cell therapy group). Participants assigned to the 1-time injection group conduct cell therapy within 1 month after bone marrow aspiration. Before implementing cell therapy, implement hepatic artery catheterization which inserts a catheter into the hepatic artery through the right aorta femoralis and inject 5X107 autologous bone marrow-derived mesenchymal stem cells. Participants assigned to the 2-time injection group store 1-time injection amount of mesenchymal stem cells while being cultivated after sampled from the bone marrow, and will re-inject autologous mesenchymal stem cells within 1 month after first injection. Participants will make a total of 8 hospital visits on a 4-week interval after registration, and effectiveness and safety will be evaluated based on a fixed procedure on every visit.

NCT ID: NCT01591200 Completed - Clinical trials for Alcoholic Liver Cirrhosis

Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis

Start date: June 2012
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and efficacy of mesenchymal stem cells in patients with cirrhosis of liver. Stem cells will be injected into the hepatic artery. Improvement in various parameters will be observed over 2 years.